225 related articles for article (PubMed ID: 17118192)
1. A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells.
Jaalouk DE; Lejeune L; Couture C; Galipeau J
Virol J; 2006 Nov; 3():97. PubMed ID: 17118192
[TBL] [Abstract][Full Text] [Related]
2. Transfer of activation-dependent gene expression into T cell lines by recombinant adeno-associated virus.
Zhang PX; Fuleihan RL
Gene Ther; 1999 Feb; 6(2):182-9. PubMed ID: 10435102
[TBL] [Abstract][Full Text] [Related]
3. IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.
Muckenfuss H; Hamdorf M; Avots A; Sanzenbacher R; Tschulena U; Cichutek K; Flory E
Mol Immunol; 2006 Mar; 43(8):1172-82. PubMed ID: 16125242
[TBL] [Abstract][Full Text] [Related]
4. Signal requirements for interleukin 4 promoter activation in human T cells.
Paliogianni F; Hama N; Mavrothalassitis GJ; Thyphronitis G; Boumpas DT
Cell Immunol; 1996 Feb; 168(1):33-8. PubMed ID: 8599837
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells.
Irie A; Harada K; Tsukamoto H; Kim JR; Araki N; Nishimura Y
Int Immunol; 2006 Dec; 18(12):1737-47. PubMed ID: 17077180
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of a cell model targeted to NFAT signal transduction pathway for preliminary screening of FK506-like immunosuppressants].
Xiao H; Qian L; Qin WS; Li S; Shen BF; Li Y
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):759-65. PubMed ID: 16285518
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of AMP-activated protein kinase suppresses IL-2 expression through down-regulation of NF-AT and AP-1 activation in Jurkat T cells.
Jhun BS; Lee JY; Oh YT; Lee JH; Choe W; Baik HH; Kim SS; Yoon KS; Ha J; Kang I
Biochem Biophys Res Commun; 2006 Dec; 351(4):986-92. PubMed ID: 17097050
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A-resistant transactivation of the IL-2 promoter requires activity of okadaic acid-sensitive serine/threonine phosphatases.
Nebl G; Meuer SC; Samstag Y
J Immunol; 1998 Aug; 161(4):1803-10. PubMed ID: 9712047
[TBL] [Abstract][Full Text] [Related]
9. The activation-induced expression of DHX32 in Jurkat T cells is specific and involves calcium and nuclear factor of activated T cells.
Alli Z; Nam EH; Beimnet K; Abdelhaleem M
Cell Immunol; 2005 Oct; 237(2):141-6. PubMed ID: 16414036
[TBL] [Abstract][Full Text] [Related]
10. Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes.
Wang J; Young IG
Allergy; 2007 Oct; 62(10):1131-8. PubMed ID: 17845581
[TBL] [Abstract][Full Text] [Related]
11. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
Serafini M; Bonamino M; Golay J; Introna M
Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
[TBL] [Abstract][Full Text] [Related]
12. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
13. Adjusting transgene expression levels in lymphocytes with a set of inducible promoters.
Danke C; Grünz X; Wittmann J; Schmidt A; Agha-Mohammadi S; Kutsch O; Jäck HM; Hillen W; Berens C
J Gene Med; 2010 Jun; 12(6):501-15. PubMed ID: 20527043
[TBL] [Abstract][Full Text] [Related]
14. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
Werner M; Kraunus J; Baum C; Brocker T
Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
[TBL] [Abstract][Full Text] [Related]
15. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
16. T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors.
Börner C; Kraus J; Bedini A; Schraven B; Höllt V
Mol Pharmacol; 2008 Aug; 74(2):496-504. PubMed ID: 18463202
[TBL] [Abstract][Full Text] [Related]
17. Regulation of interleukin 2 gene expression: discrepancy between enhancer activity and endogenous gene expression.
Mårtensson IL; Leanderson T
Eur J Immunol; 1989 Jan; 19(1):145-9. PubMed ID: 2537733
[TBL] [Abstract][Full Text] [Related]
18. A cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets.
Kumar S; Skeen MJ; Adiri Y; Yoon H; Vezys VD; Lukacher AE; Evavold BD; Ziegler HK; Boss JM
Cell Immunol; 2005 Oct; 237(2):131-40. PubMed ID: 16405934
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells.
Jaalouk DE; Eliopoulos N; Couture C; Mader S; Galipeau J
Hum Gene Ther; 2000 Sep; 11(13):1837-49. PubMed ID: 10986557
[TBL] [Abstract][Full Text] [Related]
20. NF45/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function.
Zhao G; Shi L; Qiu D; Hu H; Kao PN
Exp Cell Res; 2005 May; 305(2):312-23. PubMed ID: 15817156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
